U-turn by medicines watchdog means about 3,000 women with advanced forms of disease could benefit each year
Thousands of women with advanced breast cancer in England and Wales are to be offered a “gamechanging” twice-a-day pill on the NHS after a U-turn by the medicines watchdog.
Experts hailed the decision as a “landmark moment”. As many as 3,000 women every year could benefit from capivasertib for hormone receptor (HR)-positive HER2-negative breast cancer that has certain genetic mutations and has spread.
About Author
More Stories
Researchers create AI-based tool that restores age-damaged artworks in hours
23andMe’s founder wins bid to regain control of bankrupt DNA testing firm
Pragmata, the quirky science-fiction game that’s back from the dead